Catalyst Wire Dossier Catalyst Wire Dossier

OROS Oxybutynin

oxybutynin · Alza Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OROS Oxybutynin, covering 2011-05-19 to 2011-05-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence. [Phase 3]

See pricing